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Introductıon: Atrial septostomy (AS) is a complex technique used during interventions
such as; mitral balloon valvotomy, electrophysiological procedures, left atrial appendage
closure and MitraClip. Cardiac perforation occurs in 1-5% of cases even in experienced
hands. In daily practice, although AS is performed with the guidance of ﬂuoroscopy, it is
necessary to use transesophageal echocardiography (TEE) in some interventions
(MitraClip, for some cases with mitral balloon valvotomy). Here, we present, to our
knowledge, outcomes of the largest series of TEE-guided AS in our country.
Method: Our study included the results of 39 AS procedures (mean age 55.610.2)
by TEE-guided. AS was performed for mitral balloon valvotomy in 17 patients and for
MitraClip in 22 patients. Atrial septal puncture was only performed when tenting was
conﬁrmed in all of the bicaval, short axis aortic and 4 chamber views.
Results: While AS was successful in 37 (95%) of our patients, cardiac tamponade
developed in one patient (%2). In this patient, the septum was rigid and the Mullin's
sheath/needle combination was constantly directed towards the cranial region of the
septum. After trying for a long period of time, cardiac tamponade developed, and
pericardial ﬂuid beginning from the right atrium and rapidly spreading to other regions
was detected. In the meantime, the hemodynamics quickly worsened and the patient
underwent immediate pericardiocentesis and was referred to surgery. In another patient,
the septum was very thick (1.5 cm) and the Mullin's sheath/needle combination
constantly slipped towards the cranial region of the septum during AS. In this patient,
tenting was obtained only once with TEE. Since the level was as not appropriate for
MitraClip procedure, puncture was not performed. In one of the cases where AS was
performed successfully, a mobile thrombus attached to the atrial septum was detected
after the removing of the catheter from the septum. Since the patient was high risk for
surgery, he was treated with anticoagulants and on the 5th day after imaging the
thrombus was resolved without any complications.
Conclusıon: During the AS, cardiac perforation is more common particularly in
patients with a large aortic root, in those with very large or unlikely very small atrium, in
thoracic vertebral deformities, congenital heart diseases, massive pericardial effusions
and in those with previously underwent ASD closure. Although there is not sufﬁcient
information in literature about TEE-guided AS, there are some reports that have
mentioned the reduction of complications with the TEE-guided AS procedure. But,
others have reported reductions only in the duration of ﬂuoroscopywithout the reduction
of complications and an easier more speciﬁc region targeting method for AS. Our
ﬁndings suggest that TEE-guided AS may reduce the need of ﬂuoroscopy and the
duration of AS, however, this method can not absolutely prevent cardiac tamponade.
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Aım: The invention and use of stents has made percutaneous coronary intervention (PCI)
a safe, effective, and feasible revascularization method for the treatment of coronary
artery disease. Stent thrombosis, a man made disease, is the Achilles tendon of PCI yet.
The platelet to lymphocyte ratio (PLR) has been recently proposed as a marker showing
the thrombotic and inﬂammatory state, mainly in cancer patients. Data regarding PLR
and its association with adverse outcomes are lacking in patients with cardiovascular
disease. Thus, the aim of this study was to assess the predictive value of pre-procedural
PLR on development of stent thrombosis in patients undergoing coronary stent
implantation for the treatment of acute ST elevation myocardial infarction (STEMI).l 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTERS
Methods-Results: We retrospectively analyzed clinical, hematological, and angio-
graphic data of 201 patients (mean age 59.813.1 years, 74.6% men) who had
undergone PCI for acute STEMI and a further control coronary angiography due to
stable angina pectoris or acute coronary syndrome. Patients were divided into two
groups according to developing stent thrombosis (n¼147) or not (n¼54). Age, sex,
hemoglobin, C-reactive protein, stent type and length, pre and post-dilatation of the
stent did not differ between groups. The pre-procedural PLR was signiﬁcantly higher
in patients with stent thrombosis compared to patients without stent thrombosis
(17668 vs. 13562; p<0.001). The NLR was positively correlated with PLR
(r:0.623, p<0.001) but did not differ between two groups (p¼0.702) After multiple
logistic regression analysis, pre-procedural PLR remained signiﬁcant predictor of stent
thrombosis (OR: 1.009, 95% conﬁdence interval: 1.004-1.014, p<0.001). In receiver
operating characteristics analysis, the PLR> 150 had 63% sensitivity and 70%
speciﬁcity in predicting stent thrombosis.
Conclusıon: High pre-procedural PLR is a signiﬁcant and independent predictor of
stent thrombosis in patients with acute STEMI.Clinical, biochemical, hematological and procedural characteristics of
patients based on the presence of stent thrombosis
Variable
Stent thrombosis
absent n¼147
Stent thrombosis
present n¼54 p value
Age, years 60.5  13.5 57.9  11.9 0.202
Male sex, n (%) 110 (74.8) 40 (74.1) 0.913
Hypertension, n (%) 49 (33.3) 25 (46.3) 0.091
Diabetes Mellitus,
n (%)
30 (20.4) 12 (22.2) 0.775
Smoking, n (%) 76 (51.7) 26 (48.1) 0.655
Glucose, mg/dl 157  73 158  90 0.202
Creatinine, mg/dl 0.89  0.21 0.86  0.20 0.408
C-reactive protein,
mg/dl
0.66  0.40 0.77  0.33 0.109
Total cholesterol,
mg/dl
171  38 170  38 0.872
High-density
lipoprotein, mg/dl
35  9 35  9 0.933
Low-density
lipoprotein, mg/dl
108  29 104  29 0.369
Hemoglobin, g/L 14.0  1.2 14.2  1.5 0.455
Platelet count,
x109/L
251  63 293  71 <0.001
White blood cell
count, x109/L
12.20  2.82 11.55  2.86 0.152
Neutrophil count,
x109/L
9.20  2.72 8.83  2.83 0.361
Lymphocyte count,
x109/L
2.13  0.90 1.85  0.63 0.077
Neutrophil to
lymphocyte ratio
5.09  2.73 5.60  3.50 0.702
Platelet to
lymphocyte ratio
135  62 176  68 <0.001
Drug eluting stents,
n (%)
61 (41.5) 20 (37) 0.568
Stent diameter,
mm
3.0  0.4 3.0  0.4 0.980
Stent length, mm 22.15  5.65 22.98  6.62 0.533
Pre-dilatation, n (%) 118 (80.3) 44 (81.5) 0.848
Post-dilatation, n
(%)
80 (54.4) 29 (53.7) 0.928
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Introductıon: Endo-derived nitric oxide (NO) is synthesizes from L-arginine by
endothelial nitric oxide synthase (NOS3). Reduction in basal NO relase is known toJACC Vol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTpredispoze thrombosis. Stent trombosis is related to defects in generation or fonction
of NO. The aim of this study was to investigate the relationship between the
Glu298Asp polymorphism and stent thrombosis.
Patients and Method: The study was included in patient who devoloped stent
thrombosis (77) and who undeveloped stent thrombosis (31) after stent placement in
Istanbul Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and
Research Hospital, Department of Cardiology.
Results: Glu298Asp polymorphism of the study and control groups were no signif-
icant differences between the distributions of GG (p¼0.860), GT (p¼0.970), TT
(p¼0.838). Acute, subacute, late and very late stent thrombosis period, there wasn't
any statistically signiﬁcant difference between the groups of the distribution of
Glu298Asp (p¼0.478). There was no signiﬁcant difference in the distribution of
polymorphism Glu298Asp between the groups of acute (p¼0.533), subacute
(p¼0.469), late (p¼0.975) and very late (p¼0.975) stent trombosis and the control
group.
Conclusıon: Acquired defects in the formation of NO are associated in increased risk
factors of cardiovascular disease NO concentrations ﬂuctuate on a regular basis. Its
low concentrations are favorable and high concentrations have a toxic effect. Either
the decrease in the activity of NOS or over-stimulation of NO may play a role in the
development of stent trombosis. The deterioration of eNOS activity may play a role in
the development of stent thrombosis, suggesting that the publications available. In our
study, analysis of patients with and without stent thrombosis, endothelial nitric oxide
synthase Glu298Asp gene polymorphism was not signiﬁcantly different. According to
the time of stent thrombosis developed was classiﬁed as acute, subacute, late and too
late there was not a signiﬁcant different between the time of stent trombosis in the
patients with the Glu298Asp gene polymorphism.
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Objectıves: In this study, we evaluated distribution of atrial septal defect (ASD) types
which were diagnosed by transesophageal echocardiography (TEE). Also we evalu-
ated shunt ratio with cardiac catheterization and investigated results of percutaneous
closure of secundum ASD in our clinic.
Method and Results:We retrospectively evaluated 163 ASD cases between 2005 and
2013. The mean age of the patients was 36.715.1 (year), female/male ratio was; 111
(68.1%) / 52 (31.9%9). 119 (73%) cases were ostium secundum type, 29 (17.8%)
cases were sinüs venosus type (21 cases superior vena cava type, 8 cases inferior vena
cava type), 14 (8.6%) cases were ostium primum type and 1 (0.6%) case was coronary
sinüs type ASD. 89 cases were treated with surgery, 58 cases were treated with
pecutaneous tecnique and 16 cases were treated medically after cardiac catheteriza-
tion. Mean age of the secundum ASD cases which treated with percutaneous tecnique
was 36.514.9 (year) and according to TEE measurement, mean defect diameter was:
20.314.6 mm, mean anterior superior rim was: 4.83.4 mm, mean anterior inferior
rim was:18.316.9 mm, mean posterior superior rim was: 20.815.4 mm, mean
posterior inferior rim was: 17.70.8 mm. According to cardiac catheterization the
cases mean Qp/Qs ratio was: 2.31.0. Device size used for percutaneous closure of
ASD was: 22.86.8 mm. Devices used for percutaneous closure were Amplatzer
46.6% (27 cases), Lifetech 31% (18 cases), Cardioﬁx 12.1% (7 cases) and other 10.3%
(6 cases). We never used double device for the cases. The percutaneous closure
procedure was successful at 57 of 58 (98.2%) patients. In 1 patient procedure was
failed, because the device was not stabile with Minnesota maneuver, so the patient
referred to surgery. During follow up 1 more patient referred to surgery because of
device embolization and we showed residuel shunt in 1 patient in ﬁrst day control.
Thrombus on devices, device erosion or death is not observed after the procedure.
Conclusıon: Distribution of atrial septal defect types in young Turkish popülation
was; respectively: secundun ASD, sinüs venosus ASD and ostium primum ASD.
Percutaneous closure of secundum ASD which replaced surgical treatment of
secundum ASD is safe and effective method. However because of potentially serious
complication risks it should be performed in special centers which are experienced in
treating ASD.
PP-379
The Use of Bioresorbable Coronary Scaffold in the Chronic Total Occlusion
Musa S¸ahin1, Mehmet Akif Vatankulu2, Hakkı S¸ims¸ek1, Abdurrhman Tasal2,
Ercan Erdogan2, Ahmet Bacaksız2, Murat Turfan2, S¸eref Kul2, Osman Sönmez2,
Ömer Göktekin2
1Yuzunci Yil University, Faculty of Medicine, Cardiology Department, Van,
2Bezmialem Foundation University, Cardiology Department, Istanbul
Because of the length of the lesion in chronic total occlusions (CTO), sometimes
more than one stents are used and a metal jacket is prepared. The application of
bioresorbable scaffolds in such lesions appears quite attractive. However, the use of
these devices may be limited due to former occlusions in CTOs and as most of them
may contain serious calciﬁcations. Excluding a case presentation published in the
literature of BCS use in CTO, there is no any data.ERS C231
